Review
Open access
Oct 2026
Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards.
Evidence is accumulating to support feasibility and survival benefit in patients treated with matched therapy, and the incorporation of molecular targeted therapies and immunotherapy into the perioperative setting requires clinicians to understand the role of the MTB.
Yu Fujiwara, S. Kato, R. Kurzrock
· Hematology/Oncology Clinics... · 0 citations